Cargando…

Psychometric evaluation of the Taiwan Chinese version of the EORTC QLQ-PR25 for HRQOL assessment in prostate cancer patients

OBJECTIVE: To evaluate the psychometric properties of the Taiwan Chinese Version of the EORTC QLQ-PR25 health-related quality of life (HRQOL) questionnaire for patients with prostate cancer. METHODS: 135 prostate cancer patients were recruited in the urology outpatient clinic of a university teachin...

Descripción completa

Detalles Bibliográficos
Autores principales: Chang, Yu-Jun, Liang, Wen-Miin, Wu, Hsi-Chin, Lin, Hsueh-Chun, Wang, Jong-Yi, Li, Tsai-Chung, Yeh, Yi-Chun, Chang, Chih-Hung
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3495729/
https://www.ncbi.nlm.nih.gov/pubmed/22901052
http://dx.doi.org/10.1186/1477-7525-10-96
_version_ 1782249556506836992
author Chang, Yu-Jun
Liang, Wen-Miin
Wu, Hsi-Chin
Lin, Hsueh-Chun
Wang, Jong-Yi
Li, Tsai-Chung
Yeh, Yi-Chun
Chang, Chih-Hung
author_facet Chang, Yu-Jun
Liang, Wen-Miin
Wu, Hsi-Chin
Lin, Hsueh-Chun
Wang, Jong-Yi
Li, Tsai-Chung
Yeh, Yi-Chun
Chang, Chih-Hung
author_sort Chang, Yu-Jun
collection PubMed
description OBJECTIVE: To evaluate the psychometric properties of the Taiwan Chinese Version of the EORTC QLQ-PR25 health-related quality of life (HRQOL) questionnaire for patients with prostate cancer. METHODS: 135 prostate cancer patients were recruited in the urology outpatient clinic of a university teaching hospital. Each patient completed the EORTC QLQ-PR25 at every clinic visit between 2004 and 2008, totaling 633 assessments. Confirmatory factor analysis and Rasch analysis were used to evaluate the domain- and item-level psychometric properties. RESULTS: The results supported the unidimensionality of each of the four EORTC QLQ-PR25 domains (urinary, bowel, and hormonal-treatment-related symptoms, and sexual functioning). Item calibrations for each domain were found invariant across the three assessment time periods. The item-person maps showed 71.3% of item coverage for the urinary symptoms domain and 13–42.7% for the other three domains. CONCLUSIONS: The Taiwan Chinese Version of the EORTC QLQ-PR25 questionnaire is reliable and can be used to measure HRQOL over time. Adding new items to each domain may improve its clinical content coverage and measurement precision.
format Online
Article
Text
id pubmed-3495729
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-34957292012-11-13 Psychometric evaluation of the Taiwan Chinese version of the EORTC QLQ-PR25 for HRQOL assessment in prostate cancer patients Chang, Yu-Jun Liang, Wen-Miin Wu, Hsi-Chin Lin, Hsueh-Chun Wang, Jong-Yi Li, Tsai-Chung Yeh, Yi-Chun Chang, Chih-Hung Health Qual Life Outcomes Research OBJECTIVE: To evaluate the psychometric properties of the Taiwan Chinese Version of the EORTC QLQ-PR25 health-related quality of life (HRQOL) questionnaire for patients with prostate cancer. METHODS: 135 prostate cancer patients were recruited in the urology outpatient clinic of a university teaching hospital. Each patient completed the EORTC QLQ-PR25 at every clinic visit between 2004 and 2008, totaling 633 assessments. Confirmatory factor analysis and Rasch analysis were used to evaluate the domain- and item-level psychometric properties. RESULTS: The results supported the unidimensionality of each of the four EORTC QLQ-PR25 domains (urinary, bowel, and hormonal-treatment-related symptoms, and sexual functioning). Item calibrations for each domain were found invariant across the three assessment time periods. The item-person maps showed 71.3% of item coverage for the urinary symptoms domain and 13–42.7% for the other three domains. CONCLUSIONS: The Taiwan Chinese Version of the EORTC QLQ-PR25 questionnaire is reliable and can be used to measure HRQOL over time. Adding new items to each domain may improve its clinical content coverage and measurement precision. BioMed Central 2012-08-20 /pmc/articles/PMC3495729/ /pubmed/22901052 http://dx.doi.org/10.1186/1477-7525-10-96 Text en Copyright ©2012 Chang et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research
Chang, Yu-Jun
Liang, Wen-Miin
Wu, Hsi-Chin
Lin, Hsueh-Chun
Wang, Jong-Yi
Li, Tsai-Chung
Yeh, Yi-Chun
Chang, Chih-Hung
Psychometric evaluation of the Taiwan Chinese version of the EORTC QLQ-PR25 for HRQOL assessment in prostate cancer patients
title Psychometric evaluation of the Taiwan Chinese version of the EORTC QLQ-PR25 for HRQOL assessment in prostate cancer patients
title_full Psychometric evaluation of the Taiwan Chinese version of the EORTC QLQ-PR25 for HRQOL assessment in prostate cancer patients
title_fullStr Psychometric evaluation of the Taiwan Chinese version of the EORTC QLQ-PR25 for HRQOL assessment in prostate cancer patients
title_full_unstemmed Psychometric evaluation of the Taiwan Chinese version of the EORTC QLQ-PR25 for HRQOL assessment in prostate cancer patients
title_short Psychometric evaluation of the Taiwan Chinese version of the EORTC QLQ-PR25 for HRQOL assessment in prostate cancer patients
title_sort psychometric evaluation of the taiwan chinese version of the eortc qlq-pr25 for hrqol assessment in prostate cancer patients
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3495729/
https://www.ncbi.nlm.nih.gov/pubmed/22901052
http://dx.doi.org/10.1186/1477-7525-10-96
work_keys_str_mv AT changyujun psychometricevaluationofthetaiwanchineseversionoftheeortcqlqpr25forhrqolassessmentinprostatecancerpatients
AT liangwenmiin psychometricevaluationofthetaiwanchineseversionoftheeortcqlqpr25forhrqolassessmentinprostatecancerpatients
AT wuhsichin psychometricevaluationofthetaiwanchineseversionoftheeortcqlqpr25forhrqolassessmentinprostatecancerpatients
AT linhsuehchun psychometricevaluationofthetaiwanchineseversionoftheeortcqlqpr25forhrqolassessmentinprostatecancerpatients
AT wangjongyi psychometricevaluationofthetaiwanchineseversionoftheeortcqlqpr25forhrqolassessmentinprostatecancerpatients
AT litsaichung psychometricevaluationofthetaiwanchineseversionoftheeortcqlqpr25forhrqolassessmentinprostatecancerpatients
AT yehyichun psychometricevaluationofthetaiwanchineseversionoftheeortcqlqpr25forhrqolassessmentinprostatecancerpatients
AT changchihhung psychometricevaluationofthetaiwanchineseversionoftheeortcqlqpr25forhrqolassessmentinprostatecancerpatients